Graypoint LLC’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Buy
35,192
+8
+0% +$288 0.07% 181
2025
Q1
$1.1M Hold
35,184
0.07% 187
2024
Q4
$898K Sell
35,184
-13
-0% -$332 0.05% 209
2024
Q3
$996K Buy
35,197
+2
+0% +$57 0.06% 191
2024
Q2
$928K Sell
35,195
-8,826
-20% -$233K 0.06% 188
2024
Q1
$1.34M Sell
44,021
-6
-0% -$182 0.1% 149
2023
Q4
$1.24M Buy
44,027
+32
+0.1% +$899 0.1% 145
2023
Q3
$1.19M Buy
43,995
+46
+0.1% +$1.25K 0.11% 134
2023
Q2
$1.35M Hold
43,949
0.13% 114
2023
Q1
$1.58M Sell
43,949
-26
-0.1% -$937 0.17% 97
2022
Q4
$1.74M Sell
43,975
-40,026
-48% -$1.58M 0.21% 90
2022
Q3
$3.38M Hold
84,001
0.43% 57
2022
Q2
$3.53M Sell
84,001
-481,673
-85% -$20.2M 0.45% 56
2022
Q1
$22M Buy
565,674
+90
+0% +$3.51K 2.18% 10
2021
Q4
$22.5M Sell
565,584
-45,000
-7% -$1.79M 2.36% 9
2021
Q3
$22.1M Buy
610,584
+430,668
+239% +$15.6M 2.71% 7
2021
Q2
$7.38M Buy
+179,916
New +$7.38M 0.98% 30